OverviewChartNewsTraderScreen

DZ Bank Knock-Out ABBV/  DE000DQ2K045  /

Frankfurt Zert./DZB
30/08/2024  21:34:51 Chg.+0.030 Bid21:59:59 Ask21:59:59 Underlying Strike price Expiration date Option type
1.480EUR +2.07% 1.370
Bid Size: 30,000		 1.380
Ask Size: 30,000		 AbbVie Inc 210.9392 USD 31/12/2078 Put
GlobeNewswire 19/08 TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults wit...
GlobeNewswire 15/08 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire 15/08 Soleno Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 14/08 ArriVent BioPharma Reports Second Quarter 2024 Financial Results
GlobeNewswire 09/08 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2...
GlobeNewswire 08/08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/08 Aligos Therapeutics Strengthens Board with Two New Independent Directors
GlobeNewswire 08/08 Genmab Announces Financial Results for the First Half of 2024
GlobeNewswire 08/08 Genmab Updates 2024 Financial Guidance
GlobeNewswire 08/08 Royalty Pharma Reports Second Quarter 2024 Results
GlobeNewswire 07/08 Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 06/08 Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 01/08 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire 01/08 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 01/08 NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer
GlobeNewswire 01/08 Otsuka Pharmaceutical to Acquire Jnana Therapeutics Inc.
GlobeNewswire 31/07 Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors
GlobeNewswire 31/07 Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV111, a CD19 Directed in situ CAR...
GlobeNewswire 30/07 Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fun...
GlobeNewswire 28/07 Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzhei...
GlobeNewswire 25/07 Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Tre...
GlobeNewswire 24/07 Emerging Gene Therapies Signal Transformative Shift in Retinal Disorder Treatment, According to Sphe...
GlobeNewswire 24/07 Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital
GlobeNewswire 24/07 OSE Immunotherapeutics Announces Positive Efficacy Results for Lusvertikimab in the Phase 2 trial fo...
GlobeNewswire 23/07 Frontier Medicines Announces Milestone Payment in AbbVie Partnership, Following Advancement of Lead ...